Back to Search
Start Over
Novel artificial endonucleases inhibit base excision repair and potentiate the cytotoxicity of DNA-damaging agents on L1210 cells.
- Source :
-
Anti-cancer drugs [Anticancer Drugs] 1999 Jan; Vol. 10 (1), pp. 55-65. - Publication Year :
- 1999
-
Abstract
- A series of molecules with apurinic/apyrimidic (AP) endonuclease activity targeted to abasic sites in DNA, which incorporate an intercalating moiety linked to a purine base by a polyamino chain and recognize and cleave abasic sites in DNA with high efficiency, has been studied. The aim was first to establish whether these compounds were inhibitors of base excision DNA repair, since abasic sites are generated during this process. Using an extension of a recently established methodology, two members of this series have been identified as definite repair inhibitors. Secondly, the potential of using such compounds as sensitizers of alkylating agents has been investigated by determining the cytotoxic activity of these compounds on L1210 cells in culture. A concentration-dependent potentiation of nitrosoureas has been demonstrated, but interpretation is complicated by the inherent cytotoxic properties of the test compounds themselves. Such molecules, however, provide interesting lead compounds for new strategies aimed at enhancing the cytotoxic potential of clinically useful DNA-damaging agents.
- Subjects :
- Animals
Antibiotics, Antineoplastic pharmacology
Base Pairing
Carmustine pharmacology
DNA, Neoplasm biosynthesis
DNA, Neoplasm drug effects
Drug Screening Assays, Antitumor
Inhibitory Concentration 50
Leukemia L1210 genetics
Methyl Methanesulfonate pharmacology
Mice
Protein Biosynthesis
Proteins drug effects
RNA biosynthesis
RNA drug effects
Streptozocin pharmacology
Thiotepa pharmacology
Tumor Cells, Cultured
Antineoplastic Agents, Alkylating pharmacology
DNA Repair drug effects
Endonucleases pharmacology
Leukemia L1210 drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0959-4973
- Volume :
- 10
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Anti-cancer drugs
- Publication Type :
- Academic Journal
- Accession number :
- 10194548
- Full Text :
- https://doi.org/10.1097/00001813-199901000-00008